BMP signaling is fairly well-described in the pathogenesis of pulmonary arterial hypertension (PAH), primarily through clinical data associating BMP receptor type II (BMPR2) gene mutations with familial PAH. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.